MODULATORS OF METABOLISM AND THE TREATMENT OF DISORDERS RELATED THERETO

摘要

The present invention relates to 4-[5-methyl-6-(2-methyl-pyridin-3-yloxy)- pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester, pharmaceutically acceptable salts, solvates and hydrates thereof that are modulators of glucose metabolism. Accordingly, compounds of the present invention are useful in the treatment of metabolic-related disorders and complications thereof, such as, diabetes and obesity.